Key statistics
On Monday, Tiziana Life Sciences Ltd (0RP:BER) closed at 0.895, 129.49% above the 52 week low of 0.39 set on Mar 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.915 |
---|---|
High | 0.945 |
Low | 0.895 |
Bid | 0.79 |
Offer | 1.02 |
Previous close | 0.93 |
Average volume | 0.00 |
---|---|
Shares outstanding | 103.09m |
Free float | 63.74m |
P/E (TTM) | -- |
Market cap | 105.15m USD |
EPS (TTM) | -0.1726 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 19:08 BST.
More ▼
Announcements
- Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
- Tiziana Life Sciences Appoints New Chief Executive Officer
- Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
- Tiziana Life Sciences Granted FDA Fast Track Designation
- Tiziana Receives $3.4 Million in Non-Dilutive Funding
- Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
- FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
- Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
- Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
- Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
More ▼